Zhejiang Dayang Biology Technology Co.,Ltd.
SZSE:003017.SZ
30.6 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 382.366 | 131.111 | 131.883 | 69.36 | 53.12 | 30.276 | 41.211 | 35.996 | 29.278 | 67.637 | 55.177 |
| Short Term Investments
| -0.339 | 296.478 | 279.765 | 370.082 | -4.287 | -4.692 | -5.097 | -5.871 | 0 | 0.05 | 0.847 |
| Cash and Short Term Investments
| 382.366 | 427.589 | 411.648 | 439.442 | 53.12 | 30.276 | 41.211 | 35.996 | 29.278 | 67.687 | 56.024 |
| Net Receivables
| 121.575 | 165.861 | 150.728 | 172.407 | 119.121 | 149.571 | 106.319 | 88.746 | 68.353 | 62.68 | 100.072 |
| Inventory
| 152.23 | 126.871 | 161.608 | 69.836 | 82.39 | 81.31 | 57.208 | 43.793 | 67.822 | 60.951 | 42.605 |
| Other Current Assets
| 5.462 | 7.841 | 18.715 | 16.606 | 10.963 | 8.758 | 19.055 | 25.337 | 42.333 | 35.811 | 34.224 |
| Total Current Assets
| 661.634 | 728.163 | 742.699 | 698.29 | 265.593 | 269.915 | 223.792 | 193.872 | 207.786 | 227.13 | 232.078 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 671.494 | 616.167 | 528.022 | 433.57 | 274.17 | 247.653 | 221.806 | 198.553 | 180.42 | 164.264 | 150.159 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 93.354 | 95.364 | 56.729 | 57.48 | 58.166 | 57.728 | 38.467 | 34.633 | 35.546 | 28.398 | 28.795 |
| Goodwill and Intangible Assets
| 93.354 | 95.364 | 56.729 | 57.48 | 58.166 | 57.728 | 38.467 | 34.633 | 35.546 | 28.398 | 28.795 |
| Long Term Investments
| 55.179 | -293.977 | -277.248 | -368.173 | 6.743 | 7.241 | 8.103 | 12.679 | 8.158 | 9.389 | 0 |
| Tax Assets
| 44.169 | 45.371 | 5.545 | 4.118 | 3.966 | 4.149 | 3.82 | 3.389 | 0 | 0 | 0 |
| Other Non-Current Assets
| 20.843 | 316.885 | 318.599 | 403.515 | 36.962 | 14.919 | 17.09 | 23.59 | 26.969 | 34.121 | 30.321 |
| Total Non-Current Assets
| 885.039 | 779.811 | 631.648 | 530.511 | 380.007 | 331.69 | 289.287 | 272.844 | 251.093 | 236.173 | 209.275 |
| Total Assets
| 1,546.672 | 1,507.974 | 1,374.347 | 1,228.801 | 645.6 | 601.605 | 513.079 | 466.716 | 458.879 | 463.302 | 441.352 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 189.417 | 125.774 | 149.159 | 168.475 | 80.33 | 97.813 | 60.322 | 54.623 | 69.901 | 77.151 | 74.056 |
| Short Term Debt
| 181.307 | 282.143 | 139.071 | 85.004 | 23 | 23 | 75 | 147 | 158.1 | 161.083 | 152 |
| Tax Payables
| 6.402 | 15.001 | 4.176 | 4.561 | 4.69 | 3.022 | 5.336 | 3.219 | 0 | 0 | 0 |
| Deferred Revenue
| 58.682 | 8.031 | 25.47 | 11.924 | 20.571 | 3.022 | 16.771 | 11.661 | 0 | 0 | 0 |
| Other Current Liabilities
| 0.85 | 62.29 | 3.464 | -64.888 | 6.74 | 22.935 | 11.786 | 13.771 | 21.114 | 28.2 | 27.875 |
| Total Current Liabilities
| 430.256 | 478.239 | 317.165 | 200.515 | 130.641 | 146.77 | 163.88 | 227.055 | 249.115 | 266.435 | 253.931 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 69.061 | 0 | 40.667 | 49.867 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 11.353 | 11.961 | 9.596 | 11.248 | 9.777 | 10.323 | 11.485 | 10.312 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 27.795 | 32.724 | 16.21 | 9.041 | 7.096 | 3.895 | 11.485 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | -11.485 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 108.209 | 44.686 | 66.473 | 70.156 | 16.873 | 14.219 | 11.485 | 10.312 | 0 | 0 | 0 |
| Total Liabilities
| 538.465 | 522.924 | 383.637 | 270.671 | 147.514 | 160.989 | 175.365 | 237.367 | 249.115 | 266.435 | 253.931 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 84 | 60 | 60 | 60 | 45 | 45 | 41.5 | 35 | 33.058 | 33.058 | 33.058 |
| Retained Earnings
| 395.674 | 383.116 | 336.709 | 303.566 | 232.094 | 175.097 | 130.094 | 105.771 | 106.18 | 81.765 | 63.816 |
| Accumulated Other Comprehensive Income/Loss
| 42.045 | 49.096 | 30.009 | 30.573 | 220.992 | 220.52 | 166.12 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 486.488 | 492.837 | 563.991 | 563.991 | 0 | 0 | 0 | 88.467 | 60.792 | 79.386 | 79.386 |
| Total Shareholders Equity
| 1,008.207 | 985.049 | 990.709 | 958.13 | 498.086 | 440.617 | 337.714 | 229.238 | 200.029 | 194.209 | 176.26 |
| Total Equity
| 1,008.207 | 985.049 | 990.709 | 958.13 | 498.086 | 440.617 | 337.714 | 229.349 | 200.101 | 195.165 | 177.213 |
| Total Liabilities & Shareholders Equity
| 1,546.672 | 1,507.974 | 1,374.347 | 1,228.801 | 645.6 | 601.605 | 513.079 | 466.716 | 449.216 | 461.6 | 431.144 |